We report a case of an advanced refractory Gastric AD which responded
favourably to a combination regimen of AGI and other chemotherapy agents
which were selected on the basis of multi-analyte tumor profiling. The
treatment was well tolerated with transient manageable adverse events
and yielded radiological partial response.